Loading clinical trials...
Loading clinical trials...
A Randomized, Double-Blind, Vehicle-Controlled, Multi-Center Study to Evaluate the Efficacy and Safety of AN2690 Topical Solution, 5%, vs. Solution Vehicle in the Treatment of Onychomycosis of the Toenail in Adults
Conditions
Interventions
AN2690 Topical Solution, 5%
Solution Vehicle
Locations
27
United States
Investigational Site
Tucson, Arizona, United States
Investigational Site
Hot Springs, Arkansas, United States
Investigational Site
Burbank, California, United States
Investigational Site
Los Angeles, California, United States
Investigational Site
San Francisco, California, United States
Investigational Site
Denver, Colorado, United States
Start Date
December 1, 2010
Primary Completion Date
November 30, 2012
Completion Date
January 8, 2013
Last Updated
February 22, 2019
Lead Sponsor
Pfizer
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions